Completed PHASE2 INTERVENTIONAL 5-arm NCT02462187

Topical NVN1000 for the Treatment of External Genital and Perianal Warts

A Phase 2, Multi-center, Double-blind, Randomized, Vehicle-controlled, Ascending Dose Study Assessing Tolerability, Safety, and Efficacy of Topical NVN1000 in Subjects With External Genital Warts and Perianal Warts

Sponsor: Novan, Inc.

Conditions Genital Warts Perianal Warts

Interventions NVN1000 16% NVN1000 24% NVN1000 8% Gel Vehicle

Updated 12 times since 2017 Last updated: Apr 4, 2023 Started: Jun 12, 2015 Primary completion: Oct 31, 2016 Completion: Oct 17, 2016

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE2 trial investigates Genital Warts and Perianal Warts and is currently completed. Novan, Inc. leads this study, which shows 12 recorded versions since 2015 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

12 versions recorded

Jun 2025 — Present [monthly]

Completed PHASE2
Oct 2024 — Jun 2025 [monthly]

Completed PHASE2
Sep 2024 — Oct 2024 [monthly]

Completed PHASE2
Jul 2024 — Sep 2024 [monthly]

Completed PHASE2
May 2023 — Jul 2024 [monthly]

Completed PHASE2

▶ Show 7 earlier versions

Apr 2022 — May 2023 [monthly]

Completed PHASE2
Jan 2021 — Apr 2022 [monthly]

Completed PHASE2
Nov 2018 — Jan 2021 [monthly]

Completed PHASE2
Jun 2018 — Nov 2018 [monthly]

Completed PHASE2
Jan 2018 — Jun 2018 [monthly]

Completed PHASE2

Status: Active Not Recruiting → Completed
Feb 2017 — Jan 2018 [monthly]

Active Not Recruiting PHASE2
Jan 2017 — Feb 2017 [monthly]

Active Not Recruiting PHASE2

First recorded

Jun 2015

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Novan, Inc.
PPD Development, LP

Data source: Novan, Inc.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Atlanta, United States , Corpus Christi, United States , Fountain Valley, United States , Houston, United States , Indianapolis, United States , Lomita, United States , Metairie, United States , Philadelphia, United States , Portland, United States , Roswell, United States and 4 more locations